A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6/2 1J mouse model of Huntington's disease

Physiology and Behavior

Volumn 103, Issue 5, 2011, Pages 501-507

  Ruskin, David N ^a   Ross, Jessica L ^a   Kawamura, Masahito ^a   Ruiz, Tiffany L ^a   Geiger, Jonathan D ^b   Masino, Susan A ^a  

^a TRINITY COLLEGE   (United States)

^b UNIVERSITY OF NORTH DAKOTA   (United States)

Author keywords

Body weight; Ketones; Lifespan; Motor coordination; Sex differences; Spontaneous alternation; Working memory

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; FEMALE; HUNTINGTON CHOREA; KETOGENIC DIET; LIFESPAN; LOCOMOTION; MALE; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; WEIGHT REDUCTION; WORKING MEMORY;

3-HYDROXYBUTYRIC ACID; AGE FACTORS; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; HUNTINGTON DISEASE; KAPLAN-MEIER ESTIMATE; KETOGENIC DIET; LONGEVITY; MALE; MAZE LEARNING; MEMORY, SHORT-TERM; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; NUCLEAR PROTEINS; ROTAROD PERFORMANCE TEST; SEX CHARACTERISTICS; WEIGHT LOSS;

EID: 79954609892     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2011.04.001     Document Type: Article

References (68)

1. The Huntington's Research Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983.
2. Huntington G. On chorea Med Surg Report 1872, 26:317-321.
3. van der Burg J.M.M., Björkqvist M., Brundin P. Beyond the brain: widespread pathology in Huntington's disease. Lancet Neurol 2009, 8:765-774.
4. Koroshetz W.J., Jenkins B.G., Rosen B.R., Beal M.F. Energy metabolism defects in Huntington's disease and effects of coenzyme Q10. Ann Neurol 1997, 41:160-165.
5. Lodi R., Schapira A.H.V., Manners D., Styles P., Wood N.W., Taylor D.J., et al. Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy. Ann Neurol 2000, 48:72-76.
6. Gu M., Gash M.T., Mann V.M., Javoy-Agid F., Cooper J.M., Schapira A.H. Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol 1996, 39:385-389.
7. Browne S.E., Bowling A.C., MacGarvey U., Baik M.J., Berger S.C., Muqit M.M.K., et al. Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann Neurol 1997, 41:646-653.
8. Sawa A., Wiegand G.W., Cooper J., Margolis R.L., Sharp A.H., Lawler J.F., et al. Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat Med 1999, 5:1194-1198.
9. Masino S.A., Kawamura M., Wasser C.D., Pomeroy L.T., Ruskin D.N. Adenosine, ketogenic diet and epilepsy: the emerging therapeutic relationship between metabolism and brain activity. Curr Neuropharmacol 2009, 7:257-268.
10. Veech R.L. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 2004, 70:309-319.
11. Prins M.L., Fujima L.S., Hovda D.A. Age-dependent reduction of cortical contusion volume by ketones after traumatic brain injury. J Neurosci Res 2005, 82:413-420.
12. Hu Z.G., Wang H.D., Jin W., Yin H.X. Ketogenic diet reduces cytochrome c release and cellular apoptosis following traumatic brain injury in juvenile rats. Ann Clin Lab Sci 2009, 39:76-83.
13. Tai K.-K., Nguyen N., Pham L., Truong D.D. Ketogenic diet prevents cardiac arrest-induced cerebral ischemic neurodegeneration. J Neural Transm 2008, 115:1011-1017.
14. Puchowicz M.A., Zechel J.L., Valerio J., Emancipator D.S., Xu K., Pundik S., et al. Neuroprotection in diet-induced ketotic rat brain after focal ischemia. J Cereb Blood Flow Metab 2008, 28:1907-1916.
15. Yamada K.A., Rensing N., Thio L.L. Ketogenic diet reduces hypoglycemia-induced neuronal death in young rats. Neurosci Lett 2005, 385:210-214.
16. Zhao Z., Lange D.J., Voustianiouk A., MacGrogan D., Ho L., Suh J., et al. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci 2006, 7:29.
17. Yang X., Cheng B. Neuroprotective and anti-inflammatory activities of ketogenic diet on MPTP-induced neurotoxicity. J Mol Neurosci 2010, 42:145-153.
18. Cheng B., Yang X., Chen C., Cheng D., Xu X., Zhang X. d-β-hydroxybutyrate prevents MPP+-induced neurotoxicity in PC12 cells. Neurochem Res 2010, 35:444-451.
19. Noh H.S., Kim Y.S., Kim Y.H., Han J.Y., Park C.H., Kang A.K., et al. Ketogenic diet protects the hippocampus from kainic acid toxicity by inhibiting the dissociation of Bad from 14-3-3. J Neurosci Res 2006, 84:1829-1836.
20. Izumi Y., Ishii K., Benz A.M., Zorumski C.F. β-hydroxybutyrate fuels synaptic function during development - histological and physiological evidence in rat hippocampal slices. J Clin Invest 1998, 101:1121-1132.
21. Kashiwaya Y., Takeshima T., Mori N., Nakashima K., Clarke K., Veech R.L. d-β-Hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc Natl Acad Sci USA 2000, 97:5440-5444.
22. Bough K.J., Wetherington J., Hassel B., Pare J.F., Gawryluk J.W., Greene J.G., et al. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann Neurol 2006, 60:223-235.
23. Ahola-Erkkilä S., Carroll C., Peltola-Mjösund K., Tulkki V., Mattila I., Seppänen-Laasko T., et al. Ketogenic diet slows down mitochondrial myopathy progression in mice. Hum Mol Genet 2010, 19:1974-1984.
24. Al-Zaid N.S., Dashti H.M., Mathew T.C., Juggi J.S. Low carbohydrate ketogenic diet enhances cardiac tolerance to global ischemia. Acta Cardiol 2007, 62:381-389.
25. DeVivo D.C., Leckie M.P., Ferrendelli J.S., McDougal D.B. Chronic ketosis and cerebral metabolism. Ann Neurol 1978, 3:331-337.
26. Nakazawa M., Kodama S., Matsuo T. Effects of ketogenic diet on electroconvulsive threshold and brain contents of adenosine nucleotides. Brain Dev 1983, 5:375-380.
27. Pan J.W., Bebin E.M., Chu W.J., Hetherington H.P. Ketosis and epilepsy: 31P spectroscopic imaging at 4.1T. Epilepsia 1999, 40:703-707.
28. Sullivan P.G., Rippy N.A., Dorenbos K., Concepcion R.C., Agarwal A.K., Rho J.M. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann Neurol 2004, 55:576-580.
29. Noh H.S., Lee H.P., Kim D.W., Kang S.S., Cho G.J., Rho J.M., et al. A cDNA microarray analysis of gene expression profiles in rat hippocampus following a ketogenic diet. Mol Brain Res 2004, 129:80-87.
30. Balietti M., Giorgetti B., Di Stefano G., Casoli T., Platano D., Solazzi M., et al. A ketogenic diet increases succinic dehydrogenase (SDH) activity and recovers age-related decrease in numeric density of SDH-positive mitochondria in cerebellar Purkinje cells of late-adult rats. Micron 2010, 41:143-148.
31. Balietti M., Fattoretti P., Giorgetti B., Casoli T., Di Stefano G., Solazzi M., et al. A ketogenic diet increases succinic dehydrogenase activity in aging cardiomyocytes. Ann NY Acad Sci 2009, 1171:377-384.
32. Studzinski C.M., MacKay W.A., Beckett T.L., Henderson S.T., Murphy M.P., Sullivan P.G., et al. Induction of ketosis may improve mitochondrial function and decrease steady-state amyloid-β precursor protein (APP) levels in the aged dog. Brain Res 2008, 1226:209-217.
33. Kang H.-C., Kim H.D., Lee Y.M., Han S.H. Landau-Kleffner syndrome with mitochondrial respiratory chain-complex I deficiency. Pediatr Neurol 2006, 35:158-161.
34. Joshi C.N., Greenberg C.R., Mhanni A.A., Salman M.S. Ketogenic diet in Alpers-Huttenlocher syndrome. Pediatr Neurol 2009, 40:314-316.
35. Seo J.H., Lee Y.M., Lee J.S., Kim S.H., Kim H.D. A case of Ohtahara syndrome with mitochondrial respiratory chain complex I deficiency. Brain Dev 2010, 32:253-257.
36. Nylen K., Velazquez J.L.P., Likhodii S.S., Cortez M.A., Shen L., Leshchenko Y., et al. A ketogenic diet rescues the murine succinic semialdehyde dehydrogenase deficient phenotype. Exp Neurol 2008, 210:449-457.
37. Jarrett S.G., Milder J.B., Liang L.-P., Patel M. The ketogenic diet increases mitochondrial glutathione levels. J Neurochem 2008, 106:1044-1051.
38. Milder J.B., Liang L.-P., Patel M. Acute oxidative stress and systemic Nrf2 activation by the ketogenic diet. Neurobiol Dis 2010, 40:238-244.
39. Maalouf M., Sullivan P.G., Davis L., Kim D.Y., Rho J.M. Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience 2007, 145:256-264.
40. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996, 87:493-506.
41. Ma T.C., Buescher J.L., Oatis B., Funk J.A., Nash A.J., Carrier R.L., et al. Metformin therapy in a transgenic mouse model of Huntington's disease. Neurosci Lett 2007, 411:98-103.
42. Morton A.J., Hunt M.J., Hodges A.K., Lewis P.D., Redfern A.J., Dunnett S.B., et al. A combination drug therapy improves cognition and reverses gene expression changes in a mouse model of Huntington's disease. Eur J Neurosci 2005, 21:855-870.
43. Wood N.I., Carta V., Milde S., Skillings E.A., McAllister C.J., Ang Y.L.M., et al. Responses to environmental enrichment differ with sex and genotype in a transgenic mouse model of Huntington's disease. PLoS One 2010, 5:e9077.
44. Morales L.M., Estévez J., Suárez H., Villalobos R., Chacín de Bonilla L., Bonilla E. Nutritional evaluation of Huntington disease patients. Am J Clin Nutr 1989, 50:145-150.
45. Sanberg P.R., Fibiger H.C., Mark R.F. Body weight and dietary factors in Huntington's disease patients compared with matched controls. Med J Aust 1981, 1:407-409.
46. Djoussé L., Knowlton B., Cupples L.A., Marder K., Shoulson I., Myers R.H. Weight loss in early stage of Huntington's disease. Neurology 2002, 59:1325-1330.
47. Myers R.H., Sax D.S., Koroshetz W.J., Mastromauro C., Cupples L.A., Kiely D.K., et al. Factors associated with slow progression in Huntington's disease. Arch Neurol 1991, 48:800-804.
48. Lanska D.J., Lanska M.J., Lavine L., Schoenberg B.S. Conditions associated with Huntington's disease at death: a case-control study. Arch Neurol 1988, 45:878-880.
49. Mayeux R., Stern Y., Herman A., Greenbaum L., Fahn S. Correlates of early disability in Huntington's disease. Ann Neurol 1986, 20:727-731.
50. Lange K.W., Sahakian B.J., Quinn N.P., Marsden C.D., Robbins T.W. Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer type matched for degree of dementia. J Neurol Neurosurg Psychiatry 1995, 58:598-606.
51. Lawrence A.D., Sahakian B.J., Hodges J.R., Rosser A.E., Lange K.W., Robbins T.W. Executive and mnemonic functions in early Huntington's disease. Brain 1996, 119:1633-1645.
52. Pang T.Y.C., Stam N.C., Nithianantharajah J., Howard J.L., Hannan A.J. Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice. Neuroscience 2006, 141:569-584.
53. Lione L.A., Carter R.J., Hunt M.J., Bates G.P., Morton A.J., Dunnett S.B. Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. J Neurosci 1999, 19:10428-10437.
54. von Hörsten S., Schmitt I., Nguyen H.P., Holzmann C., Schmidt T., Walther T., et al. Transgenic rat model of Huntington's disease. Hum Mol Genet 2003, 12:617-624.
55. Ashizawa T., Wong L.-J.C., Richards C.S., Caskey C.T., Jankovic J. CAG repeat size and clinical presentation in Huntington's disease. Neurology 1994, 44:1137-1143.
56. Duyao M., Ambrose C., Myers R., Novelletto A., Persichetti F., Frontali M., et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat Gen 1993, 4:387-392.
57. Mantis J.G., Fritz C.L., Marsh J., Heinrichs S.C., Seyfried T.N. Improvement in motor and exploratory behavior in Rett syndrome mice with restricted ketogenic and standard diets. Epilepsy Behav 2009, 15:133-141.
58. Oishi K., Sakamoto K., Konishi M., Murata Y., Itoh N., Sei H. FGF21 is dispensable for hypothermia induced by fasting in mice. Neuroendocrinol Lett 2010, 31:101-105.
59. Pan Y., Larson B., Araujo J.A., Lau W., de Rivera C., Santana R., et al. Dietary supplementation with medium-chain TAG has long-lasting cognition-enhancing effects in aged dogs. Br J Nutr 2010, 103:1746-1754.
60. Xu K., Sun X., Eroku B.O., Tsipis C.P., Puchowicz M.A., LaManna J.C. Diet-induced ketosis improves cognitive performance in aged rats. Adv Exp Biol Med 2010, 662:71-75.
61. Su S.W., Sogawa M.R.C.Y., Silveira D.C., Holmes G.L., Stafstrom C.E. Timing of ketogenic diet initiation in an experimental epilepsy model. Dev Brain Res 2000, 125:131-138.
62. Zhao Q., Stafstrom C.E., Fu D.D., Hu Y., Holmes G.L. Detrimental effects of the ketogenic diet on cognitive function in rats. Pediatr Res 2004, 55:498-506.
63. Silva M.C., Rocha J., Pires C.S., Ribeiro L.C., Brolese G., Leite M.C., et al. Transitory gliosis in the CA3 hippocampal region in rats fed on a ketogenic diet. Nutr Neurosci 2005, 8:259-264.
64. Todorova M.T., Tandon P., Madore R.A., Stafstrom C.E., Seyfried T.N. The ketogenic diet inhibits epileptogenesis in EL mice: a genetic model for idiopathic epilepsy. Epilepsia 2000, 41:933-940.
65. Hori A., Tandon P., Holmes G.L., Stafstrom C.E. Ketogenic diet: effects on expression of kindled seizures and behavior in adult rats. Epilepsia 1997, 38:750-758.
66. Wing R.R., Vazquez J.A., Ryan C.M. Cognitive effects of ketogenic weight-reducing diets. Int J Obes Relat Metab Disord 1995, 19:811-816.
67. Brinkworth G.D., Buckley J.D., Noakes M., Clifton P.M., Wilson C.J. Long-term effects of a very low-carbohydrate diet and a low-fat diet on mood and cognitive function. Arch Int Med 2009, 169:1873-1880.
68. Halyburton A.K., Brinkworth G.D., Wilson C.J., Noakes M., Buckley J.D., Keogh J.B., et al. Low- and high-carbohydrate weight-loss diets have similar effects on mood but not cognitive performance. Am J Clin Nutr 2007, 86:580-587.